Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beam Therapeutics, Inc.

18.24
+1.247.29%
Post-market: 18.270.0300+0.16%17:45 EDT
Volume:3.28M
Turnover:60.42M
Market Cap:1.77B
PE:-3.98
High:19.48
Open:16.78
Low:16.66
Close:17.00
Loading ...

BofA Securities Upgrades Beam Therapeutics to Buy From Neutral

MT Newswires Live
·
28 Mar

Beam Therapeutics Inc : Bofa Global Research Raises to Buy From Neutral

THOMSON REUTERS
·
28 Mar

Beam Therapeutics New Drug Application for Alpha-1 Antitrypsin Deficiency Gets FDA Clearance

MT Newswires Live
·
28 Mar

Beam announces FDA clearance of BEAM-302 investigational new drug application

TIPRANKS
·
28 Mar

BRIEF-Beam Therapeutics Announces Clearance Of Investigational New Drug Application For BEAM-302 For The Treatment Of Alpha-1 Antitrypsin Deficiency (AATD) By The United States (U.S.) Food And Drug Administration

Reuters
·
28 Mar

Beam Therapeutics Announces Clearance of Investigational New Drug Application for Beam-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (Aatd) by the United States (U.S.) Food and Drug Administration

THOMSON REUTERS
·
28 Mar

Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) by the United States (U.S.) Food and Drug Administration

GlobeNewswire
·
28 Mar

Beam Therapeutics (BEAM) Down 21.4% Since Last Earnings Report: Can It Rebound?

Zacks
·
27 Mar

Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics today

TIPRANKS
·
26 Mar

Cathie Wood Bets on Baidu as Chinese AI Buzz Intensifies, Ark Loads up on $12.4 Million Worth of Stock

Benzinga
·
25 Mar

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

Zacks
·
19 Mar

Is Beam Therapeutics Inc. (BEAM) the Best Growth Stock to Invest in for the Next 10 Years?

Insider Monkey
·
16 Mar

Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts

TIPRANKS
·
15 Mar

Beam Therapeutics Inc : Citigroup Raises Target Price to $64 From $56

THOMSON REUTERS
·
13 Mar

BEAM Down Despite Positive Initial Data From Genetic Disorder Study

Zacks
·
12 Mar

Beam Therapeutics Inc : Jonestrading Raises to Buy From Hold

THOMSON REUTERS
·
11 Mar

Cathie Wood’s ARK Investment buys 485K shares of Beam Therapeutics today

TIPRANKS
·
11 Mar

Beam Therapeutics Raised to Sector Outperform From Sector Perform by Scotiabank

Dow Jones
·
11 Mar

Beam Therapeutics Raised to Buy From Hold by Jones Trading

Dow Jones
·
11 Mar

Beam Therapeutics Shares Drop After $500M Offering Prices

Dow Jones
·
11 Mar